Clinical Trials List
2023-07-03 - 2026-12-31
Phase II/III
Recruiting4
ICD-10A31.0
Pulmonary mycobacterial infection
ICD-9031.0
Pulmonary diseases due to other mycobacteria
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- JENG-SEN TSENG Division of Hematology & Oncology
- 顏廷廷 Division of Otolaryngology
- 馮士釗 Division of Ophthalmology
- 覃俊士 Division of General Internal Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蕭慈慧 Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- 余文光 Division of Thoracic Medicine
- 黃仲儒 Division of Thoracic Medicine
- 林泰祺 Division of Ophthalmology
- Wei-Zhi Chen Division of Thoracic Medicine
- 潘聖衛 Division of Thoracic Medicine
- 廖文輝 無
- 廖文輝 Division of Otolaryngology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yu Lin Division of Emergency Medicine
- Shang-Yi Lin Division of Others -
- Ming-Ju Tsai Division of Thoracic Medicine
- 陳家閔 Division of General Internal Medicine
- 莊政皓 Division of Thoracic Medicine
- 鄭孟軒 Division of Thoracic Medicine
- Inn-Wen Chong Division of Thoracic Medicine
- Chau-Chyun Sheu Division of Thoracic Medicine
- KUAN-LI WU Division of Thoracic Medicine
- Po-Liang Lu Division of Infectious Disease
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHUN-TA HUANG Division of General Internal Medicine
- HSIN-YUN SUN Division of Infectious Disease
- Jung-Yien Chien Division of Thoracic Medicine
- 李孟叡 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
124 participants
